Health & Life Sciences

Overview

As a stakeholder in the health and life sciences sector, you work every day to improve human health and enhance patient care. Our national health and life sciences team partners with industry leaders like you — biotech innovators, pharmaceutical and medical device manufacturers, health systems, investors, and digital health pioneers — to help you thrive in a landscape defined by rapid change and increasingly complex regulatory demands.

Our professionals have extensive practical experience to help you navigate the sector’s most critical business and legal challenges. We advise on transformative mergers and acquisitions, strategic investments, and capital deployment, ensuring your transactions are efficient and positioned for long-term growth and innovation. Our team handles high-stakes litigation and government investigations, providing sophisticated advocacy and clear strategic guidance when challenges arise.

We support you throughout the business life cycle — structuring and negotiating technology transactions, licensing, and collaborations; guiding you through complex regulatory requirements at all stages of the product lifecycle; and implementing proactive risk management and compliance solutions. Our capabilities also encompass employee benefits and executive compensation, privacy and data security, outsourcing, intellectual property, and public policy strategy, helping you seize opportunities and mitigate risk in every aspect of your operations.

Our team includes former in-house counsel to major health systems and global life sciences companies, as well as former FDA, other federal agency and Capitol Hill health policy advisors, and former Department of Justice attorneys. With this blend of industry insight and legal acumen, we deliver practical, business-minded solutions tailored to your most complex challenges so you can continue advancing your mission and achieving your strategic objectives in a rapidly evolving sector.

Health & Life Sciences

Overview

Health & Life Sciences Segments

Insights & Events

Latest

FDA-Related Legislative and Regulatory Proposals and Funding Change the President's FY27 Budget

Federal Court Approves Flexible Damages Approach in $70 Million Trade-Secret Verdict

Minnesota PFAS Reporting: Deadline Extension and Enhanced Support

Bankruptcy Court Dismisses Adversary Complaint Against CMS for Terminating Debtors’ Provider Status

Expert Witness Practice in U.S. Drug and Medical Device Litigation

Jennifer Breuer Named a 2026 ‘Notable Leaders in Health Care’ Honoree by Crain’s Chicago Business

Wayne Mason Inducted as Fellow to the International Academy of Trial Lawyers

EPA Extends PFAS Reporting Start Date under TSCA Section 8(a)(7)

AI-Enabled Medical Devices: Navigating New Liability Risks and Regulatory Frontiers

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

Insights

FDA-Related Legislative and Regulatory Proposals and Funding Change the President's FY27 Budget

Federal Court Approves Flexible Damages Approach in $70 Million Trade-Secret Verdict

Minnesota PFAS Reporting: Deadline Extension and Enhanced Support

Bankruptcy Court Dismisses Adversary Complaint Against CMS for Terminating Debtors’ Provider Status

Expert Witness Practice in U.S. Drug and Medical Device Litigation

EPA Extends PFAS Reporting Start Date under TSCA Section 8(a)(7)

The Intel Report: Quarterly National Security Briefing

National Policy Framework for Artificial Intelligence, and Other Developments

China Issued New Regulations to Protect Trade Secrets

Federal Appellate Courts Continue to Require That Trade Secrets Be Defined and Definite

Events

Past Events

AI-Enabled Medical Devices: Navigating New Liability Risks and Regulatory Frontiers

The Impact of AI on the Pharmacy Industry: Managing its Risks and Benefits

Data, Dangers, & Developments in Drug Supply Chain Security & Safety

Privacy and Genetic Data

Acquisitions and Divestitures: Perspectives on Buying and Selling Assets

News

Jennifer Breuer Named a 2026 ‘Notable Leaders in Health Care’ Honoree by Crain’s Chicago Business

Wayne Mason Inducted as Fellow to the International Academy of Trial Lawyers

Faegre Drinker Grows FDA Team in D.C., Adds Leading Partners Jeremiah Kelly and Justin Coen to Government and Regulatory Practice

Faegre Drinker Welcomes Finance Partner Eleni Zodiates to London, Further Strengthening Its UK Finance & Restructuring Team

Health Care Attorney Isaac Willett Rejoins Faegre Drinker in Indianapolis

Jessica Natali Honored With Temple Law’s 2026 Women’s Law Caucus Leadership Award

Faegre Drinker Practices and Attorneys Ranked Among Leaders in Chambers Global Guide 2026

Faegre Drinker Shortlisted for 2026 Global Competition Review Awards

Faegre Drinker Announces 2026 Leadership Transitions

Faegre Drinker Welcomes Labor & Employment Counsel Stephanie Albrecht in Los Angeles

Related Legal Services

Experience

Our Experience

Surmodics Inc. Agrees to $627M Acquisition by GTCR

Mineralys Therapeutics, Inc. Enters into $100M ATM Equity Offering Sales Agreement

Cook Medical Litigates National MDL Involving IVC Filter

Elevance Health Enters Strategic Partnership to Advance Primary Care Delivery

Faegre Drinker Represents Miromatrix Medical Inc. in Sale of Company to United Therapeutics Corporation

TT Capital Partners Purchases All Equity Interests of Cantata Health Solutions

Meet The Team

Meet The Full Health & Life Sciences Team

Maureen Donahue Hardwick

Michael B. Abbott

Matt Abdifar

Jessica C. Abrahams

Reed Abrahamson

Alison M. Agnew

Stephanie Albrecht

Nicholas B. Alford

Andrew Anderson

Josh Anderson

Lynne Anne Anderson

Jeremy Andrews

Emilija Andrulyte

Nicholas R. Arens

Chemaine A. Athias-Williams

Maddie Augustus

Abdullah M. Azkalany

Heather B. Bader

Brian M. Balduzzi

Peter W. Baldwin

Ian J. Bambrick

Libby Baney Burstein

Thomas J. Barton

Michael N. Baxter

Wayne Beck